Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion type Assertion NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_head.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion description "[RAIA metastatic FCDTC are overrepresented with RAS mutations, whereas RAI refractory metastatic thyroid cancers are enriched with BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion evidence source_evidence_literature NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion SIO_000772 23533233 NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion wasDerivedFrom befree-2016 NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.
- NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_assertion wasGeneratedBy ECO_0000203 NP1063971.RAMPb1MrykU9nyu833qMGVvN-iEuBn2BP2JUwEtjA-x3w130_provenance.